Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc. (CCRN) Market Cap

Cross Country Healthcare, Inc. has a market capitalization of $321.9M.

Financials based on reported quarter end 2025-12-31

Price: $9.96

-0.24 (-2.35%)

Market Cap: 321.89M

NASDAQ · time unavailable

CEO: Kevin Cronin Clark

Sector: Healthcare

Industry: Medical - Care Facilities

IPO Date: 2001-10-25

Website: https://www.crosscountryhealthcare.com

Cross Country Healthcare, Inc. (CCRN) - Company Information

Market Cap: 321.89M · Sector: Healthcare

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company operates in two segments, Nurse and Allied Staffing and Physician Staffing. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing; staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, RPO, and consulting services. It also provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. This segment serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand as independent contractors on temporary assignments at various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.

Analyst Sentiment

60%
Buy

Based on 14 ratings

Analyst 1Y Forecast: $10.61

Average target (based on 2 sources)

Consensus Price Target

Low

$9

Median

$11

High

$14

Average

$11

Potential Upside: 6.5%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CROSS COUNTRY HEALTHCARE INC (CCRN) — Investment Overview

🧩 Business Model Overview

CROSS COUNTRY HEALTHCARE INC (CCRN) operates as a healthcare workforce solutions provider, connecting clinical organizations with qualified clinicians through managed staffing and recruitment services. The core value chain runs from (1) recruiting and credentialing clinicians, (2) matching them to demand signals from healthcare providers, (3) deploying clinicians to assignments (travel or per-diem/locum needs), and (4) managing ongoing operational requirements such as compliance, scheduling, and performance.

The demand side is typically hospitals, health systems, and other healthcare delivery organizations facing variable labor needs and specialized clinical coverage gaps. Supply-side strength is critical: recruiters, compliance workflows, and clinician retention efforts drive the ability to fill open shifts quickly and reliably. This creates practical stickiness for customers because staffing providers are embedded into procurement and vendor management processes, and assignment success depends on established clinician networks and operational execution.

💰 Revenue Streams & Monetisation Model

Revenue is primarily generated through staffing-related services where CCRN earns a spread between (a) amounts paid to clinicians (wages and related costs) and (b) billings to healthcare clients. Monetisation is therefore heavily tied to utilization, bill rates, and productivity (the ability to fill roles efficiently and reduce unproductive bench time).

Revenue character typically includes:

  • Transactional staffing revenue from per-assignment billings for travel and temporary coverage.
  • Recurring or semi-recurring components when customers use CCRN under ongoing vendor programs, statement-of-work structures, or managed service frameworks that smooth demand and improve predictability.
  • Value-added services such as recruitment, compliance support, and workforce management offerings that can increase customer dependence and raise effective retention.

Margin drivers generally include clinician utilization, wage cost management, billing discipline, credentialing efficiency, and the mix of higher-margin specialties and contract structures. When bill rates and utilization move together, operating leverage can appear; when the labor market is tight or pricing power weakens, spreads can compress.

🧠 Competitive Advantages & Market Positioning

CCRN’s moat is best described as a combination of switching costs, operational scale in credentialing and deployment, and reputation-based trust rather than a purely technology-led network effect.

  • Switching costs (hard to replicate quickly): Clinical staffing engagements require proven performance, background/credentialing workflows, and integration into client scheduling and vendor processes. Once a provider demonstrates reliability, procurement teams typically prefer continuity to reduce coverage risk.
  • Supply-side depth and matching efficiency: Healthcare labor demand can be volatile by specialty and location. Scale recruiting, compliance infrastructure, and clinician pipeline management improve match rates and reduce time-to-fill.
  • Regulatory/compliance execution as an advantage: Credentialing and labor compliance are operationally intensive. Competitors can enter the space, but replicating the required process discipline across a broad clinician base is difficult.
  • Customer relationships and contract embeddedness: Managed services and ongoing staffing programs deepen coordination and make displacement incremental rather than abrupt.

Overall, competitors can compete on pricing, but dislodging an established staffing partner usually requires sustained improvements in both coverage reliability and unit economics—barriers that take time to build.

🚀 Multi-Year Growth Drivers

The medium- to long-term opportunity in healthcare staffing is supported by durable demand factors that extend beyond cycle timing. Key drivers include:

  • Workforce shortages and demographic demand: Aging populations and persistent clinician capacity constraints increase the need for supplemental labor and specialized coverage.
  • Flexibility and risk management by providers: Hospitals and health systems frequently shift variable labor demand into staffing networks rather than absorbing all fixed headcount risk.
  • Continued shift toward contract and travel models: In many markets, staffing solutions remain a structural component of labor planning.
  • Specialty expansion and higher-complexity coverage: Broadening into hard-to-fill specialties can improve revenue mix and utilization when supply constraints persist.
  • Managed service frameworks: Vendor programs can convert one-off coverage into longer, more repeatable commercial relationships.

Over a 5–10 year horizon, total addressable market expansion is driven less by “share capture” in a static market and more by the growing role of staffing as an operational tool for delivering care amid ongoing labor constraints.

⚠ Risk Factors to Monitor

  • Labor market and pricing spread risk: Competition among staffing firms can pressure bill rates; wage inflation can compress margins if contract pricing does not keep pace.
  • Regulatory and compliance exposure: Changes in labor regulations, credentialing requirements, reimbursement policies, or enforcement intensity can affect operating costs and eligibility.
  • Customer procurement and contract concentration: If large customers re-tender or consolidate vendors, renewal rates and pricing can deteriorate.
  • Operational execution risk: Assignment failures, credentialing errors, or process breakdowns can lead to client attrition and cost overruns.
  • Technology-driven disintermediation: Pure marketplaces and automation may reduce search friction, but healthcare credentialing and deployment complexity limits full replacement; the risk is gradual commoditization of certain staffing segments.
  • Capital and working-capital dynamics: Staffing models can be sensitive to timing of clinician payroll and client collections; adverse working-capital conditions can stress liquidity.

📊 Valuation & Market View

Equity market valuation for staffing and healthcare services providers is commonly anchored to earnings power and cash generation resilience rather than technology-style multiples. Investors often focus on:

  • Revenue quality and utilization trends (how much revenue converts to operating profit).
  • Gross spread durability between billings and clinician-related costs.
  • Operating leverage as volume scales and overhead absorption improves.
  • Cash flow conversion, particularly working-capital discipline in payroll and receivables cycles.
  • Contract and customer mix that can influence revenue stability.

In practice, the key valuation “needle movers” are the sustainability of pricing/billing discipline, the ability to maintain utilization during labor-market swings, and evidence that compliance and operational processes protect retention.

🔍 Investment Takeaway

CCRN’s long-term investment case rests on its ability to function as a reliable conduit between healthcare demand and clinician supply, supported by operational scale in recruiting, credentialing, and deployment. The moat is primarily switching costs and execution-based trust—customers tend not to change staffing partners lightly because coverage risk is costly. Growth prospects are tied to structurally elevated demand for flexible healthcare labor and the continued preference for staffing solutions that reduce fixed labor risk for providers. The principal debate centers on whether operating spreads and utilization can be sustained through labor-market and competitive cycles.


⚠ AI-generated — informational only. Validate using filings before investing.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"Crescent Healthcare (CCRN) reported a revenue of $236.76M for the year ended December 31, 2025, but faced a net loss of $82.93M, reflecting challenges in profitability. The company has total assets amounting to $448.95M and total liabilities of $126.13M, resulting in a healthy equity position of $322.82M and a negative net debt of -$106.42M, indicating a net cash position. The operating cash flow was $18.24M, pointing to a positive cash generation capability, though capital expenditures were zero. Notably, there are no dividends paid to shareholders, and the stock has experienced a significant one-year decline of 35%. Despite a year-to-date change of approximately 21%, reflecting some recovery, the overall performance remains concerning. The analyst's price target consensus is $10.61, suggesting potential upward movement from the current price of $9.75, though the recent negative price trends should be considered cautiously. Overall, CCRN exhibits strengths in cash flow and balance sheet but struggles with profitability and price stability."

Revenue Growth

Fair

The revenue of $236.76M shows reasonable scale; however, growth dynamics are unclear.

Profitability

Neutral

A net loss of $82.93M raises concerns about sustainable profitability.

Cash Flow Quality

Positive

Operating cash flow of $18.24M indicates adequate cash generation capacity.

Leverage & Balance Sheet

Good

Strong balance sheet with net cash position, total equity at $322.82M.

Shareholder Returns

Neutral

No dividends paid, and significant decline in stock price over the past year.

Analyst Sentiment & Valuation

Neutral

Analyst price target suggests potential upside, though current trends are negative.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Management sounded confident about execution and called out a credible end-2026 target: >$1B revenue run-rate and 4%–5% adjusted EBITDA margin. However, in the Q&A the margin story was less about improving gross margins and more about cost/operating leverage—explicitly citing offshoring more work to India and automation, while acknowledging the travel market remains hypercompetitive and the bill-pay spread likely stays tight. The analyst pressure centered on “what needs to happen” to reach the higher margin exit rate; management’s answer leaned on return on revenue-producer investments plus operating leverage rather than any meaningful gross margin rescue. On labor disruption, management downplayed risk: Q4 revenue did not include any significant strike/labor disruption revenue, while Q1 impact was only in the single millions, used as evidence that disruptions won’t derail core momentum. Market-wise, they cited stabilization with average bill rates around $90–$95.

AI IconGrowth Catalysts

  • Return to more normal contingent utilization cycle (travel/nurse/allied) as travelers on assignment stabilize and rise into Q2
  • Investments in revenue producers (recruiters, account managers, sales professionals) starting early 2026; “sequential progression” expected
  • Expansion of proprietary technology (Intellify) beyond core MSP/VMS into additional “whole house” markets in 2026
  • Higher-margin mix contribution from home-based, physician, and education staffing businesses lifting consolidated gross margin over time

Business Development

  • Renewed/expanded/won >$400 million in contract value predominantly with MSP clients (from prior quarter highlight)
  • Whole-house strategy: positioning Intellify/VMS and staffing solutions across locums and home-based (Q&A scope of expansion includes home-based, education, locums)

AI IconFinancial Highlights

  • Q4 revenue: $237M, down 5% sequentially and down 24% YoY
  • Full-year revenue: $1.05B, down 22% YoY
  • Q4 gross margin: 20.3%; down 10 bps sequentially; up 30 bps YoY
  • Full-year adjusted EBITDA: $27M (2.5% of revenue); Q4 adjusted EBITDA: $4M (1.7% of revenue)
  • Guidance Q1 2026 revenue: $235M–$240M; exit 2026: Q4 revenue >$250M
  • Guidance Q1 2026 adjusted EBITDA: $4M–$5M (~2% margin); expected payroll tax headwind of ~$2M in Q1
  • Guidance gross margin assumption for Q1: 19.5%–20.0%
  • Q1 adjusted EPS: loss of $0.04 to $0.06 (avg ~31.5M shares)
  • Impairment/one-time items: noncash impairment charges of $78M related to indefinite-lived assets/goodwill and abandonment of trade names; merger termination payment produced a $20M credit (acquisition/integration net credit $16M Q4, $3M FY)

AI IconCapital Funding

  • Cash balance (Q4 end): $109M; no outstanding debt
  • Q4 share repurchase: >800,000 shares (~2.5% of shares outstanding) for $6.8M
  • Additional repurchases in Q1 2026 to date: 486,000 shares (as of call date)
  • FY cash from operations: $48M; Q4 cash from operations: $18M
  • Credit facility: exploring renewal/rightsizing to lower carrying costs of unused facility

AI IconStrategy & Ops

  • Margin exit path relies more on operating leverage than large gross margin expansion (hypercompetitive travel bill-pay spread expected to persist)
  • Operational levers cited for reaching 4%–5% EBITDA by end of 2026: offshoring more work to India center of excellence and automation of activities
  • ERP middle-office functionality rollout and AI to improve recruiter productivity/speed to market (prepared remarks; reinforced as efficiency lever)
  • DSO in Q4: 58 days (in line with 60-day goal)

AI IconMarket Outlook

  • Exit 2026 targets reiterated: revenue run rate >$1B and adjusted EBITDA margin of 4%–5%
  • Q1 2026 travel momentum: projected travelers on assignment rising through Q1; exit Q1 up ~2% vs Q4 average
  • Average bill rates cited by management (market backdrop): ~$90–$95; no “typical bump up” in Allied Health winter, implying consistent QoQ improvement in Allied and Travel Nursing
  • Travel outlook in prepared remarks: flat to up slightly sequentially; travelers on assignment growth each month into Q2
  • Intellify expansion timeline: 2026; “coming to market later this year, hopefully sooner”

AI IconRisks & Headwinds

  • Travel bill-pay spread compression and continued hypercompetitive travel market; management said they do not anticipate margin pressure easing for travel in the near term
  • Competitive pressures limit gross margin expansion; EBITDA improvement expected from operating leverage instead
  • Labor disruption/strike risk: management participated in two strike/labor disruption events; impact stated as “not material” in Q4 and “single millions” in Q1
  • International candidate pipeline risk: retrogression remains due to annual visa caps; backlog slowly clearing but is monitored
  • Payroll tax headwind: approximately $2M negative impact in Q1 2026 guidance

Sentiment: MIXED

Note: This summary was synthesized by AI from the CCRN Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
📁

SEC Filings (CCRN)

© 2026 Stock Market Info — Cross Country Healthcare, Inc. (CCRN) Financial Profile